OPTINOSE, INC. Deferred Tax Assets, Valuation Allowance
OPTINOSE, INC. had Deferred Tax Assets, Valuation Allowance of $124.40 million as of 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2025-03-26
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $124.40M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $118.27M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $115.72M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $125.08M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2024-12-31 | $124.40M 10-K · filed 2025-03-26 |
| 2023-12-31 | $118.27M 10-K · filed 2025-03-26 |
| 2022-12-31 | $115.72M 10-K · filed 2024-03-07 |
| 2021-12-31 | $125.08M 10-K · filed 2023-03-07 |
| 2020-12-31 | $104.89M 10-K · filed 2022-03-08 |
| 2019-12-31 | $78.94M 10-K · filed 2021-03-03 |
| 2018-12-31 | $52.62M 10-K · filed 2020-03-05 |
| 2017-12-31 | $35.63M 10-K · filed 2019-03-06 |
| 2016-12-31 | $27.14M 10-K · filed 2018-03-13 |